SkinBioTherapeutics plc (AIM:SBTX)

London · Delayed Price · Currency is GBP · Price in GBX

9.88

-0.38 (-3.66%)

Aug 14, 2026, 4:29 PM GMT

SkinBioTherapeutics Balance Sheet

Financials in millions GBP. Fiscal year is July - June.

Millions GBP. Fiscal year is Jul - Jun.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	3.12	4.78	0.8	1.31	1.8	4.61
Cash & Short-Term Investments	3.12	4.78	0.8	1.31	1.8	4.61
Cash Growth	152.61%	496.75%	-38.95%	-27.32%	-60.85%	113.51%
Accounts Receivable	0.76	0.62	0.28	0	0	-
Other Receivables	-	0.79	0.06	0.3	0.33	0.21
Receivables	0.76	1.41	0.34	0.3	0.33	0.21
Inventory	0.93	0.8	0.47	0.03	0.12	-
Prepaid Expenses	-	0.12	0.06	0.07	0.08	0.24
Total Current Assets	4.81	7.11	1.67	1.72	2.33	5.06
Property, Plant & Equipment	0.67	0.73	0.12	0.17	0.13	0.14
Goodwill	2.42	2.42	2.04	-	-	-
Other Intangible Assets	1.71	1.87	1.39	0.7	0.63	0.53
Total Assets	9.6	12.13	5.22	2.59	3.08	5.73

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Accounts Payable	0.65	0.51	0.28	0.19	0.07	0.08
Accrued Expenses	-	0.34	0.21	0.3	0.37	0.28
Short-Term Debt	-	-	0.74	-	-	-
Current Portion of Leases	0.1	0.11	0.04	0.03	0.03	0.03
Current Income Taxes Payable	0.03	0.03	0.03	-	0.03	0.02
Other Current Liabilities	-	0.47	0.5	0	0.01	0
Total Current Liabilities	0.78	1.47	1.8	0.53	0.51	0.4
Long-Term Debt	0.6	0.6	-	-	-	-
Long-Term Leases	0.24	0.28	0.04	0.07	0.1	0.11
Long-Term Deferred Tax Liabilities	-	0.36	0.15	-	-	-
Other Long-Term Liabilities	-	-	0.25	-	-	-
Total Liabilities	1.63	2.71	2.25	0.6	0.61	0.52

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Common Stock	2.59	2.59	2.02	1.73	1.57	1.57
Additional Paid-In Capital	21.09	21.09	14.51	10.95	8.76	8.76
Retained Earnings	-16.14	-14.7	-14	-11.12	-8.29	-5.5
Comprehensive Income & Other	0.44	0.44	0.44	0.44	0.44	0.38
Shareholders' Equity	7.98	9.42	2.97	1.99	2.48	5.22
Total Liabilities & Equity	9.6	12.13	5.22	2.59	3.08	5.73

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Total Debt	0.94	0.99	0.82	0.1	0.13	0.14
Net Cash (Debt)	2.19	3.79	-0.02	1.21	1.68	4.47
Net Cash Growth	938.28%	-	-	-27.78%	-62.48%	107.04%
Net Cash Per Share	0.01	0.02	-0.00	0.01	0.01	0.03
Filing Date Shares Outstanding	259.17	258.78	202.26	173.14	156.78	156.78
Total Common Shares Outstanding	258.78	258.78	202.26	173.14	156.78	156.78
Working Capital	4.02	5.64	-0.13	1.19	1.82	4.66
Book Value Per Share	0.03	0.04	0.01	0.01	0.02	0.03
Tangible Book Value	3.85	5.13	-0.46	1.29	1.85	4.69
Tangible Book Value Per Share	0.01	0.02	-0.00	0.01	0.01	0.03